))
Jennifer Petter: Opportunities for RNA-Targeted Therapeutics
Manage episode 441697601 series 3603216
Content provided by Bio-Techne. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Bio-Techne or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Jennifer Petter is the founder and Chief Innovation Officer at Arrakis Therapeutics. Here she discusses the moments that led up to the founding of a successful biotech company built on a remarkable new approach in drug discovery: RNA-targeting small molecules. This back of the napkin conversation covers the standout moments in Jen’s career as well as some insightful perspectives into the future of drug discovery.
Arrakis Therapeutics Website: https://arrakistx.com/
14 episodes
Share
